AbbVie Inc. (ABBV) Stock Investment Calculator & Historical Return Analysis
AbbVie is a global, research-based biopharmaceutical company that originated as a spin-off of Abbott Laboratories. The company's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. They strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. Investors often view AbbVie Inc. as a key player in the market, analyzing its long-term potential through various revenue models, brand recognition, and consistent presence in its industry.
This AbbVie Inc. stock investment calculator allows you to explore how a hypothetical investment in ABBV might have performed over time. By adjusting the investment amount and time period, you can visualize potential growth, compare outcomes across different market cycles, and better understand the impact of long-term investing.
What if you invested $1000 in ABBV on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Understanding AbbVie Inc.'s Historical Performance
AbbVie Inc.'s stock performance has historically reflected both broader market trends and company-specific milestones. Like many growth-oriented stocks, ABBV has experienced periods of growth driven by innovation and market demand.
When analyzing AbbVie Inc.'s historical returns, it's important to consider:
- Market cycles: Strong bull markets often amplify returns, while recessions can temporarily suppress performance.
- Business model evolution: Changes in revenue strategies and product lines can significantly impact stability.
- Long-term trends: Over extended periods, compounding can play a larger role than short-term price fluctuations. Try our calculator to explore returns over 5 years or larger investments over 10 years.
This calculator helps you see how these factors might have affected an investment depending on when you entered the market.
Historical Annual Returns
Over the past 13 years, AbbVie Inc. has delivered an average annual return of 21.9%. The stock peaked in 2017 with a massive +60.6% gain, while investors faced a downturn in 2015 (-7.1%). Overall, the stock finished in the green 10 times out of 13 years.
Avg Return
+21.9%
Win Rate
77%
10W - 3L
Best
+60.6%
2017
Worst
-7.1%
2015
Performance Consistency
AbbVie Inc. Annual Returns by Year
| Year | Annual Return | Start Price | End Price |
|---|---|---|---|
| 2013 | +56.38% | $21.05 | $32.92 |
| 2014 | +29.96% | $32.40 | $42.11 |
| 2015 | -7.14% | $42.39 | $39.37 |
| 2016 | +12.90% | $38.28 | $43.22 |
| 2017 | +60.61% | $43.08 | $69.19 |
| 2018 | -2.67% | $70.41 | $68.53 |
| 2019 | +4.83% | $66.33 | $69.53 |
| 2020 | +26.28% | $70.33 | $88.81 |
| 2021 | +34.61% | $87.37 | $117.60 |
| 2022 | +23.99% | $117.62 | $145.84 |
| 2023 | -0.71% | $146.53 | $145.50 |
| 2024 | +15.25% | $150.05 | $172.93 |
| 2025 | +30.84% | $174.63 | $228.49 |
Historical annual returns for AbbVie Inc.. Data shows year-over-year percentage change in stock price.
Why Use a "What If" Stock Calculator?
Many investors wonder questions such as:
- What if I had invested 5 years ago?
- How does timing affect long-term returns?
- What role does compounding play in stock investments?
A what-if investment calculator answers these questions by turning historical data into practical insights. Rather than focusing on daily price movements, it encourages a long-term perspective, which is especially useful for retirement planning, portfolio comparisons, and financial education.
Key Innovations
- ✓Humira (adalimumab), a biologic medication used to treat a variety of autoimmune diseases.
- ✓Imbruvica (ibrutinib), a targeted therapy for certain types of cancer.
- ✓Venclexta (venetoclax), a medication for chronic lymphocytic leukemia.
Business Segments
- ImmunologyThis segment includes products for the treatment of autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease.
- OncologyThis segment develops and markets treatments for various types of cancer.
- NeuroscienceThis segment focuses on treatments for neurological and psychiatric disorders.
How to Interpret the Results
The results shown are based on historical performance and are meant for educational and informational purposes only. They do not account for future market conditions, taxes, transaction fees, or individual investment strategies. Past performance does not guarantee future results, but historical analysis can help investors understand risk, volatility, and growth potential.
For best use:
- Compare multiple time ranges to see how outcomes differ
- Use consistent assumptions across different stocks
- Combine this tool with fundamental research and diversification principles